(Total Views: 499)
Posted On: 01/01/2021 11:30:20 PM
Post# of 145248
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: ClosetInvestor #70825
Reviewing trial data by the FDA that has its endpoint reducing mortality will get reviewed much faster. That was not an end point for Regeneron.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)